Rachel Rabinovitch

Rachel Rabinovitch, MD, is a Professor in the Department of Radiation Oncology at the University of Colorado Anschutz Medical Campus School of Medicine. She holds memberships in prestigious organizations including ASTRO, RTOG, and the NCI's Breast Oncology Local Disease Task Force. Her clinical practice focuses on breast cancer, Hodgkin and Non-Hodgkin lymphoma, and total body irradiation.

• Education:
  • BS, University of California–Los Angeles (1985)
  • MD, Albert Einstein College of Medicine (1989)
• Training:
  • Internship, Staten Island University Hospital (1990)
  • Residency, Memorial Sloan-Kettering Cancer Center (1993)

Her research spans breast cancer radiotherapy (including accelerated partial breast irradiation and post-mastectomy protocols) and lymphoma treatment optimization. Notably, she co-PI for NSABP B39/RTOG 0413 and NSABP B43, integrating genomic biosignatures with clinical decision-making. Google Scholar highlights her contributions to DCIS risk stratification and radiation pneumonitis prediction.

Scientific recognition includes multiple 'Top Doctor' awards (5280 Magazine, US News & World Reports) and the ASTRO Clinical Poster Recognition Award (2008). She chairs RTOG's Quality Control Committee and contributes to NCCN Guidelines® for lymphomas and chronic lymphocytic leukemia.

Clinical practice locations include the University of Colorado Cancer Center and UCHealth Radiation Oncology, with expertise in 3D conformal radiation therapy and brachytherapy. Her work emphasizes patient education and access to clinical trials.